Literature DB >> 12795504

The neonatal liver: Part III: Pathophysiology of liver dysfunction.

Debbie Fraser Askin1, William L Diehl-Jones.   

Abstract

The liver, the largest organ in the body, is critical to a number of key metabolic functions. Its also plays an important role in removing the waste products of metabolism (particularly ammonia) and in detoxifying drugs and other substances such as endogenous hormones and steroid compounds. In addition, the liver plays a major role in the production of clotting factors, plasma proteins, bile salts, and bilirubin. Many neonates display signs of hepatic dysfunction such as hyperbilirubinemia, hepatomegaly, or elevated liver enzymes. These often occur secondary to systemic illness, such as sepsis or hypoxic injury, or following the use of drugs or parenteral nutrition to treat other problems. Although rare, primary liver disease does occur in neonates and must be recognized promptly, with treatment initiated in a timely manner to prevent unnecessary sequelae. This article, the third in a series on the liver, examines causes of liver dysfunction in neonates, beginning with an overview of jaundice and hepatomegaly and moving to a discussion of specific diseases.

Entities:  

Mesh:

Year:  2003        PMID: 12795504     DOI: 10.1891/0730-0832.22.3.5

Source DB:  PubMed          Journal:  Neonatal Netw        ISSN: 0730-0832


  2 in total

1.  The role of XPD in cell apoptosis and viability and its relationship with p53 and cdk2 in hepatoma cells.

Authors:  Hong-yun Wang; Gao-fei Xiong; Ji-xiang Zhang; Hong Xu; Wu-hua Guo; Jiang-jing Xu; Xiang-yang Xiong
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

2.  XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCC.

Authors:  Zhihua Xiao; Yijun Wang; Hao Ding
Journal:  Cell Biosci       Date:  2019-01-05       Impact factor: 7.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.